Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.23 is 27% below its 5-year average of 1.69, near the low end of its 5-year range (0.79–16.16).
As of the fiscal period ended Tuesday, June 30, 2026. 13.23% above its 12-month average of 1.09.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.23.
CURRENT RATIO
1.23
CURRENT RATIO AVG TTM
1.09
CURRENT RATIO AVG 3Y
1.34
CURRENT RATIO AVG 5Y
1.69
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+13.23%
CURRENT VS 3Y AVG
-8.18%
CURRENT VS 5Y AVG
-27.14%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.54
median of 730 covered companies
CURRENT VS SECTOR MEDIAN
-65.25%
vs the sector median at left
NervGen Pharma Corp. Common stock
Market Cap
$148.36M
Current Ratio
1.23
TTM Avg
1.09
3Y Avg
1.34
5Y Avg
1.69
Market Cap
$149.15M
Current Ratio
2.47
TTM Avg
5.27
3Y Avg
13.16
5Y Avg
16.37
Market Cap
$145.36M
Current Ratio
0.82
TTM Avg
5.49
3Y Avg
4.19
5Y Avg
4.20
Market Cap
$151.52M
Current Ratio
15.62
TTM Avg
10.23
3Y Avg
11.93
5Y Avg
11.24
Market Cap
$144.66M
Current Ratio
19.47
TTM Avg
11.39
3Y Avg
11.91
5Y Avg
15.23
Market Cap
$152.74M
Current Ratio
5.55
TTM Avg
4.34
3Y Avg
4.83
5Y Avg
5.46
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NervGen Pharma Corp. Common stock (NGEN) | $148.36M | 1.23 | 1.09 | 1.34 | 1.69 |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | 0.90 | 1.03 | 0.91 | 1.08 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $149.15M | 2.47 | 5.27 | 13.16 | 16.37 |
| Korsana Biosciences, Inc. (KRSA)vs › | $145.36M | 0.82 | 5.49 | 4.19 | 4.20 |
| Anavex Life Sciences Corp. (AVXL)vs › | $151.52M | 15.62 | 10.23 | 11.93 | 11.24 |
| Codexis, Inc. (CDXS)vs › | $151.12M | 3.06 | 4.00 | 3.48 | 4.36 |
| Nyxoah S.A. (NYXH)vs › | $145.11M | 2.38 | 2.90 | 4.31 | 7.34 |
| Immuneering Corporation (IMRX)vs › | $144.66M | 19.47 | 11.39 | 11.91 | 15.23 |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.74M | 5.55 | 4.34 | 4.83 | 5.46 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $154.07M | 9.71 | 4.67 | 6.04 | 19.74 |
Current Ratio
1.23
Quick Ratio
1.23
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.23 |
| 2026-03-31 | 1.34 |
| 2025-12-31 | 1.16 |
| 2025-09-30 | 0.79 |
| 2025-06-30 | 0.92 |
| 2025-03-31 | 1.06 |
| 2024-12-31 | 1.12 |
| 2024-09-30 | 1.66 |
| 2024-06-30 | 1.78 |
| 2024-03-31 | 2.42 |
| 2023-12-31 | 0.83 |
| 2023-09-30 | 1.40 |
| 2023-06-30 | 1.73 |
| 2023-03-31 | 2.04 |
| 2022-12-31 | 2.27 |
| 2022-09-30 | 2.74 |
| 2022-06-30 | 4.25 |
| 2022-03-31 | 11.99 |
| 2021-12-31 | 16.16 |
| 2021-09-30 | 8.20 |
| 2021-06-30 | 8.11 |
| 2021-03-31 | 5.04 |
| 2020-12-31 | 8.21 |
| 2020-09-30 | 30.19 |
| 2020-06-30 | 10.29 |
| 2020-03-31 | 6.77 |
| 2019-12-31 | 6.77 |
| 2019-09-30 | 11.40 |
| 2019-06-30 | 25.72 |
| 2019-03-31 | 19.43 |
| 2018-12-31 | 5.68 |
| 2018-09-30 | 9.28 |
| 2018-06-30 | 3.15 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.00 |
